Bitetti Teresa Marie

President, OBU at TAK

Sold, on record
$855k
Dollars the filings state
Form 4 sales
1
Latest Aug 10, 2026
Form 144 notices
5
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • TAKTAKEDA PHARMACEUTICAL CO LTDPresident, OBU

Sales by reason

0
Routine
0
Plan not stated
1
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 144 notice TAKNotice
    Jul 10, 2023 2023

    Filed to sell 46,424 shares ($719k)

    Bitetti Teresa Marie, President, Global Oncology Business Unit

    No 10b5-1 planFirst sale on recordFiling

  2. 2 Form 144 notice TAKNotice
    Jul 10, 2024 +366 days

    Filed to sell 38,479 shares ($507k)

    Bitetti Teresa Marie, President, Global Oncology Business Unit

    No 10b5-1 planFirst sale on recordFiling

  3. 3 Form 144 notice TAKNotice
    Jul 9, 2025 +364 days

    Filed to sell 52,649 shares ($812k)

    Bitetti Teresa Marie, President, Global Oncology Business Unit

    No 10b5-1 planFirst sale on recordFiling

  4. 4 Form 144 notice TAKNotice
    Dec 5, 2025 +149 days

    Filed to sell 87,023 shares ($1.2M)

    Bitetti Teresa Marie, President, Global Oncology Business Unit

    No 10b5-1 planFirst sale on recordFiling

  5. 5 Form 144 notice TAKNotice
    Jul 13, 2026 +220 days

    Filed to sell 54,210 shares ($908k)

    Bitetti Teresa Marie, President, Global Oncology Business Unit

    No 10b5-1 planFirst sale on recordFiling

  6. 6 Form 4 sale TAKNo plan
    Aug 10, 2026 +28 days

    Sold 50,012 shares at $17.10 ($855k)

    Bitetti Teresa Marie, President, OBU

    No 10b5-1 planSold 16.6% of holdings ($5.2M position)252,010 shares leftFirst sale on recordFollows a Form 144Filing

Every transaction

Loading transactions…

Sales and notices (6)

Form 144 notices and Form 4 sales by Bitetti Teresa Marie
Source
Aug 10, 2026Aug 12, 2026TAKPresident, OBUForm 4 sale50,012$855k16.6%No planSEC
Jul 13, 2026Jul 13, 2026TAKPresident, Global Oncology Business UnitForm 144 notice54,210$908kNoticeSEC
Dec 5, 2025Dec 5, 2025TAKPresident, Global Oncology Business UnitForm 144 notice87,023$1.2MNoticeSEC
Jul 9, 2025Jul 9, 2025TAKPresident, Global Oncology Business UnitForm 144 notice52,649$812kNoticeSEC
Jul 10, 2024Jul 10, 2024TAKPresident, Global Oncology Business UnitForm 144 notice38,479$507kNoticeSEC
Jul 10, 2023Jul 10, 2023TAKPresident, Global Oncology Business UnitForm 144 notice46,424$719kNoticeSEC